BRAF and pancreatic intraductal papillary-mucinous neoplasm: Gene mutations and methylation analyzed by pyrosequencing included those for CDKN2A, RASSF1A, LINE1, KRAS, BRAF, and GNAS, which have been investigated in IPMN or pancreatic ductal adenocarcinoma11,17,37–40.